Propanc Biopharma appoints Ralf Brandt to scientific advisory board as it develops cancer patent
Quick facts: Propanc Biopharma Inc
Market Cap: $694.32 k
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of Propanc Biopharma Inc named herein, including the promotion by the Company of Propanc Biopharma Inc in any Content on the Site, the Company...FOR OUR FULL DISCLAIMER CLICK HERE